These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7017786)

  • 41. Phencyclidine-induced inhibition of rat prolactin secretion: increased portal blood dopamine.
    Meltzer HY; Simonovic M; Gudelsky GA
    Eur J Pharmacol; 1985 Mar; 110(1):143-6. PubMed ID: 4007050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of benztropine on the diurnal prolactin responses to haloperidol.
    Nathan RS; Perel JM; McCarthy T; Jarrett DB
    Psychoneuroendocrinology; 1985; 10(1):71-6. PubMed ID: 3889966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopaminergic stimulation of prolactin release.
    Denef C; Manet D; Dewals R
    Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible role of dopamine and noradrenaline in the regulation of prolactin secretion from an ectopic anterior pituitary gland in female rats.
    Fernández-Ruiz JJ; Cebeira M; Agrasal C; Tresguerres JA; Bartke A; Esquifino AI; Ramos JA
    J Endocrinol; 1987 Apr; 113(1):45-9. PubMed ID: 3585225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The dopaminergic regulation of anterior pituitary 45Ca2+ homeostasis and prolactin secretion.
    Schrey MP; Clark HJ; Franks S
    J Endocrinol; 1986 Mar; 108(3):423-9. PubMed ID: 3486242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of calcium ions in dopamine inhibition of prolactin secretion from sheep pituitary cells.
    Ray KP; Wallis M
    Mol Cell Endocrinol; 1982; 28(3):691-703. PubMed ID: 6818058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cells.
    Login IS; Trugman JM
    Neuropharmacology; 1989 Jun; 28(6):647-50. PubMed ID: 2547181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delayed activation of tuberoinfundibular dopamine neurons and suppression of prolactin secretion in the rat after morphine administration.
    Gudelsky GA; Passaro E; Meltzer HY
    J Pharmacol Exp Ther; 1986 Mar; 236(3):641-5. PubMed ID: 3950867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.
    Besser GM; Delitala G; Grossman A; Stubbs WA; Yeo T
    Br J Pharmacol; 1980; 71(2):569-73. PubMed ID: 6110459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Supersensitivity of anterior pituitary dopamine receptors involved in the inhibition of prolactin secretion following destruction of the medial basal hypothalamus.
    Cheung CY; Weiner RI
    Endocrinology; 1976 Sep; 99(3):914-7. PubMed ID: 954677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Number of dopamine neurons predicts prolactin levels in two inbred mouse strains.
    Sved AF; Baker H; Reis DJ
    Experientia; 1985 May; 41(5):644-6. PubMed ID: 2860004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro studies on the regulation of prolactin secretion in the bullfrog pituitary gland.
    Seki T; Kikuyama S
    Gen Comp Endocrinol; 1982 Apr; 46(4):473-9. PubMed ID: 6980164
    [No Abstract]   [Full Text] [Related]  

  • 53. Dopaminergic regulation of polyamine synthesis in the rat pituitary gland.
    Persson L; Rosengren E
    Mol Cell Endocrinol; 1987 Jun; 51(3):219-25. PubMed ID: 3109979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time-dependent increase in plasma prolactin after pituitary stalk section: role of posterior pituitary dopamine.
    Murai I; Garris PA; Ben-Jonathan N
    Endocrinology; 1989 May; 124(5):2343-9. PubMed ID: 2495929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of prostaglandins in the control of gonadotropin and prolactin secretion.
    Ojeda SR; Naor Z; Negro-Vilar A
    Prostaglandins Med; 1979 Apr; 2(4):249-75. PubMed ID: 398988
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacological evidence that neurotensin mediates prolactin-induced activation of tuberoinfundibular dopamine neurons.
    Hentschel K; Cheung S; Moore KE; Lookingland KJ
    Neuroendocrinology; 1998 Aug; 68(2):71-6. PubMed ID: 9705573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor.
    Xu R; Parlow AF; Wang Y
    Brain Res; 2002 Jun; 939(1-2):95-9. PubMed ID: 12020855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The importance of dopamine in the pathogenesis of experimental prolactinomas.
    el-Azouzi M; Hsu DW; Black PM; Jolesz F; Hedley-Whyte ET; Klibanski A; Zervas NT
    J Neurosurg; 1990 Feb; 72(2):273-81. PubMed ID: 1967303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on tuberoinfundibular dopamine neurons.
    Moore KE; Annunziato L; Gudelsky GA
    Adv Biochem Psychopharmacol; 1978; 19():193-204. PubMed ID: 696461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
    Canonico PL; Valdenegro CA; MacLeod RM
    Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.